News
Padcev/Keytruda scores again in early bladder cancer
Pfizer and Astellas now have two studies supporting the use of Padcev with MSD's Keytruda as perioperative therapy for muscle-invasive bladder cancer.
News
DBV gets peanut allergy therapy programme back on track
Shares in DBV have shot up on phase 3 results that set up a US filing for its peanut allergy therapy. which could plug a looming hole in the market.
R&D
Bringing therapies to patients quicker with integrated CDMO ...
Biotechs and pharmaceutical companies can receive enormous value from a trusted partnership with an integrated CDMO and CRO.
R&D
Sponsored
Unlocking the future of obesity treatment
Obesity is more than a number on the scale, it’s a complex, malignant disease linked to diabetes, cardiovascular conditions, and even certain cancers.
R&D
GLP-1s in CKD: Evidence, market leadership, and key insights...
At ASN Kidney Week 2025, Glucagon-like peptide-1 (GLP-1) receptor agonists moved firmly into the nephrology spotlight.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
